Perioperative medicine & outcomes

The association between volatile anaesthetic exposure and postoperative complications following bariatric surgery: A multicentre retrospective cohort study

J Clin AnesthPublished Retrospective cohort study

Authors' conclusion

Cumulative volatile anaesthetic exposure was independently associated with increased postoperative complications following bariatric surgery. The association with reoperation rate appears to be a class effect, while sevoflurane, but not isoflurane, is associated with an increased risk of AKI.

Study context

Population
Patients undergoing laparoscopic bariatric procedures at four Israeli centres (January 2017-May 2025)included in final analysis
Participants
16,685 patients
Exposure
Cumulative volatile anaesthetic exposure; sevoflurane vs isoflurane
Outcome
Reoperation (within 30 days) and AKI (within 7 days)
Methodological detailsmulticentre, mixed-effects logistic regression
  • Multicentre
  • Mixed-effects logistic regression

Main finding

As reported in the abstract

Reoperation and AKI per higher total MAChr exposure
Higher total MAChr exposureOdds ratio (95 % CI)P value
Reoperation
1.75(1.35–2.26)
P < 0.001
AKI
1.35(1.05–1.70)
P = 0.015

Per higher total MAChr exposure, as printed

Patients

Reoperation
122 (0.7 %)
Acute kidney injury (AKI)
96 (0.6 %)

Observational data: associations, not effects.

Further findings

AKI by agent

OR (95 % CI)P value
Sevoflurane1.53 (1.20–1.90)P < 0.001
Isoflurane0.89 (0.55–1.38)P = 0.630
OutcomeP value
AKI by agentSevoflurane vs IsofluraneP = 0.012

Reoperation by agent

Isoflurane and sevoflurane showed comparable associations with reoperation risk

Original publication

The association between volatile anaesthetic exposure and postoperative complications following bariatric surgery: A multicentre retrospective cohort study. J Clin Anesth. Published 7 October 2025. doi:10.1016/j.jclinane.2025.112020

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.